HIGHLIGHTS
- who: Binghong He and Qiong Yang from the Beijing Key Laboratory of Gene Resource and Molecular Development, College of Life Sciences, Beijing Normal University, Beijing, China have published the paper: Recent Development of LDL-Based Nanoparticles forCancer Therapy, in the Journal: Pharmaceuticals 2023, 16, 18. of /2023/
- what: The authors compare the advantages and disadvantages of these three particles .
SUMMARY
LDLR, a transmembrane glycoprotein consisting of 4536 amino_acid residues, is one of the largest monomeric proteins. Given this function, Krieger et_al combined cytotoxic drugs with LDL to form LDL-based NPs . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.